SCHEMBL30510418

SCHEMBL30510418

COC(=O)N(C1c2ccccc2-c2ccccc21)[C@@H](Cc1cccc(F)c1F)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPIA P62937 3/20 0.37
▸ PIN1 Q13526 2/20 0.33
▸ GUCY1A1 Q02108 1/20 0.33
▸ GUCY1B1 Q02153 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CACNA1G O43497 1/20 0.33
▸ CACNA1H O95180 1/20 0.33
▸ CACNA1I Q9P0X4 1/20 0.33
▸ BMP1 P13497 1/20 0.33
▸ KMT2A Q03164 1/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ ITGB1 P05556 1/20 0.32
▸ ITGA4 P13612 1/20 0.32
▸ CTSA P10619 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25186515 0.92 PPIA (0.41) PPIAKMT2AITGB1ITGA4CYP2D6
SCHEMBL27215385 0.92 PPIA (0.41) PPIAKMT2AITGB1ITGA4CYP2D6
SCHEMBL30510414 0.90 PPARG (0.33) PPIAKMT2ACHRM3CYP2D6SLC6A2
SCHEMBL25179592 0.90 PPIA (0.31) PPIACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL27078234 0.90 PPARG (0.33) PPIAKMT2ACHRM3CYP2D6SLC6A2
SCHEMBL30510268 0.88 PPIA (0.34) PPIAKMT2AITGB1ITGA4PPARG
SCHEMBL25178701 0.88 PPIA (0.34) PPIAKMT2AITGB1ITGA4PPARG
SCHEMBL25182298 0.85 PPIA (0.33) PPIAPPARGPPARACYP1A2TSHR
SCHEMBL30767804 0.84 PPARG (0.39) KMT2AITGB1ITGA4CYP2D6SLC6A2
SCHEMBL25179578 0.84 PPARG (0.39) KMT2AITGB1ITGA4CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12371454-B2 Cyclic peptide compound having Kras inhibitory action CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-07-29 — — US disclosed
US-20240400617-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-12-05 — — US disclosed
US-20230151060-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151060-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION KRAS, NRAS, HRAS PPIA 749/4885PIN1 47/4885GUCY1A1 2655/4885
US-20240400617-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION KRAS, NRAS, HRAS PPIA 749/4885PIN1 47/4885GUCY1A1 2655/4885
US-12371454-B2 Cyclic peptide compound having Kras inhibitory action KRAS, NRAS, HRAS PPIA 749/4885PIN1 47/4885GUCY1A1 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback